Total Payments
$19,065
2024 Payments
$4,384
Companies
44
Transactions
907
Medicare Patients
6,675
Medicare Billing
$582,828
Payment Breakdown by Category
Food & Beverage$18,634 (97.7%)
Education$431.42 (2.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,634 | 901 | 97.7% |
| Education | $431.42 | 6 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,287 | 204 | $0 (2024) |
| Janssen Biotech, Inc. | $2,065 | 106 | $0 (2024) |
| LEO Pharma Inc. | $1,181 | 73 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,113 | 37 | $0 (2024) |
| Lilly USA, LLC | $1,056 | 51 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $1,048 | 49 | $0 (2024) |
| GENZYME CORPORATION | $937.82 | 29 | $0 (2024) |
| Incyte Corporation | $864.85 | 35 | $0 (2024) |
| Galderma Laboratories, L.P. | $749.40 | 34 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $704.90 | 39 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,384 | 193 | ABBVIE INC. ($810.39) |
| 2023 | $3,692 | 176 | ABBVIE INC. ($693.36) |
| 2022 | $3,296 | 180 | ABBVIE INC. ($613.13) |
| 2021 | $1,400 | 82 | AbbVie Inc. ($357.85) |
| 2020 | $515.85 | 24 | Janssen Biotech, Inc. ($109.74) |
| 2019 | $1,686 | 71 | EPI Health, LLC ($305.93) |
| 2018 | $1,830 | 87 | Ortho Dermatologics, a division of Bausch Health US, LLC ($323.12) |
| 2017 | $2,263 | 94 | Aqua Pharmaceuticals ($464.53) |
All Payment Transactions
907 individual payment records from CMS Open Payments — Page 2 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.44 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $26.21 | General |
| Category: Dermatology | ||||||
| 10/28/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.89 | General |
| Category: Immunology | ||||||
| 10/25/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $112.79 | General |
| Category: Dermatology | ||||||
| 10/25/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: Dermatology | ||||||
| 10/23/2024 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $101.70 | General |
| Category: Dermatology | ||||||
| 10/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $43.49 | General |
| Category: Immunology | ||||||
| 10/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.99 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply), Odomzo | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Dermatology | ||||||
| 10/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Immunology | ||||||
| 10/18/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $10.81 | General |
| Category: Dermatology | ||||||
| 10/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.23 | General |
| Category: Immunology | ||||||
| 10/17/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Inflammation | ||||||
| 10/16/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $29.34 | General |
| Category: DERMATOLOGY | ||||||
| 10/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $31.21 | General |
| Category: Immunology | ||||||
| 10/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $29.59 | General |
| Category: Immunology | ||||||
| 10/07/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $34.42 | General |
| Category: Immunology | ||||||
| 10/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Immunology | ||||||
| 10/04/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: DERMATOLOGY | ||||||
| 10/01/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $40.14 | General |
| Category: Immunology | ||||||
| 09/30/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.50 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,982 | 3,638 | $492,291 | $162,967 |
| 2022 | 20 | 1,788 | 3,368 | $509,616 | $170,589 |
| 2021 | 18 | 1,547 | 2,921 | $355,041 | $146,054 |
| 2020 | 18 | 1,358 | 2,472 | $225,460 | $103,217 |
Total Patients
6,675
Total Services
12,399
Medicare Billing
$582,828
Procedure Codes
74
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 3 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 29 | 29 | $4,166 | $1,626 | 39.0% |
| 17111 | Destruction of 15 or more non-cancerous skin growths | Office | 2021 | 13 | 17 | $4,091 | $1,610 | 39.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $2,899 | $1,550 | 53.5% |
| 11900 | Injection of up to 7 skin growths | Office | 2021 | 23 | 30 | $3,175 | $1,216 | 38.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 45 | 89 | $3,634 | $1,019 | 28.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 53 | 312 | $2,977 | $299.98 | 10.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 393 | 613 | $58,235 | $36,588 | 62.8% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 99 | 115 | $16,675 | $10,591 | 63.5% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 103 | 116 | $30,740 | $8,880 | 28.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 93 | 93 | $13,950 | $7,424 | 53.2% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 131 | 131 | $16,230 | $7,368 | 45.4% |
| 17004 | Destruction of 15 or more skin growths | Office | 2020 | 39 | 55 | $15,125 | $7,288 | 48.2% |
| 17000 | Destruction of skin growth | Office | 2020 | 128 | 161 | $15,295 | $6,326 | 41.4% |
| 12032 | Repair of wound (2.6 to 7.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs | Office | 2020 | 18 | 19 | $7,980 | $5,184 | 65.0% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 100 | 120 | $7,865 | $4,164 | 52.9% |
| 17003 | Destruction of 2-14 skin growths | Office | 2020 | 102 | 666 | $23,310 | $3,213 | 13.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 17 | 17 | $2,635 | $1,378 | 52.3% |
| 11104 | Punch biopsy of single skin lesion | Office | 2020 | 11 | 13 | $4,550 | $1,244 | 27.3% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2020 | 20 | 27 | $3,915 | $1,225 | 31.3% |
| 10060 | Drainage of abscess | Office | 2020 | 13 | 13 | $2,015 | $1,147 | 56.9% |
| 11900 | Injection of up to 7 skin growths | Office | 2020 | 14 | 15 | $1,125 | $501.78 | 44.6% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 26 | 32 | $1,600 | $293.04 | 18.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2020 | 36 | 251 | $3,765 | $268.67 | 7.1% |
| 87177 | Smear for parasites | Office | 2020 | 15 | 15 | $450.00 | $132.96 | 29.5% |
About Dr. Daniel Navi, M.D
Dr. Daniel Navi, M.D is a Dermatology healthcare provider based in Palo Alto, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2007. The National Provider Identifier (NPI) number assigned to this provider is 1215121280.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Navi, M.D has received a total of $19,065 in payments from pharmaceutical and medical device companies, with $4,384 received in 2024. These payments were reported across 907 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($18,634).
As a Medicare-enrolled provider, Navi has provided services to 6,675 Medicare beneficiaries, totaling 12,399 services with total Medicare billing of $582,828. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Palo Alto, CA
- Active Since 08/31/2007
- Last Updated 03/02/2017
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1215121280
Products in Payments
- DUPIXENT (Biological) $1,927
- SKYRIZI (Biological) $1,603
- TREMFYA (Drug) $1,554
- TALTZ (Drug) $1,029
- OPZELURA (Drug) $864.85
- ADBRY (Biological) $732.59
- RINVOQ (Biological) $697.78
- ILUMYA (Biological) $559.11
- Humira (Biological) $536.83
- COSENTYX (Biological) $492.34
- EUCRISA (Drug) $476.46
- ENSTILAR (Drug) $443.44
- XTRAC (Device) $443.01
- Sotyktu (Drug) $358.03
- Sitavig (Drug) $348.90
- Cimzia (Drug) $337.58
- REMICADE (Biological) $309.60
- SILIQ (Drug) $307.94
- Otezla (Drug) $306.57
- HUMIRA (Biological) $238.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Palo Alto
John Doux, M.d, M.D
Dermatology — Payments: $124,944
Dermatology $124,944
Joyce Teng, Md, MD
Dermatology — Payments: $115,109
Dermatology $115,109
Shireen Guide, Md, MD
Dermatology — Payments: $79,371
Dermatology $79,371
Ilka Netravali, Md, MD
Dermatology — Payments: $28,025
Dermatology $28,025
Dr. Thomas Hoffman, M.d, M.D
Dermatology — Payments: $17,860
Dermatology $17,860
Dr. Miguel Canales, M.d, M.D
Dermatology — Payments: $8,023
Dermatology $8,023